Related references
Note: Only part of the references are listed.Targets for immunotherapy of liver cancer
Tim F. Greten et al.
JOURNAL OF HEPATOLOGY (2018)
MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms
Sander P. J. Joosten et al.
GASTROENTEROLOGY (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Structural and Functional Impacts of ER Coactivator Sequential Recruitment
Ping Yi et al.
MOLECULAR CELL (2017)
Targeting the hepatocyte growth factor/Met pathway in cancer
Dinuka M. De Silva et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Monocytes promote liver carcinogenesis in an oncogene-specific manner
Vladislava Juric et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma
Antonio Mazzocca et al.
CANCER RESEARCH (2015)
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Yasuyuki Kihara et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Met as a therapeutic target in HCC: Facts and hopes
Silvia Giordano et al.
JOURNAL OF HEPATOLOGY (2014)
Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Lipika Goyal et al.
CLINICAL CANCER RESEARCH (2013)
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma
Eugene Sokolov et al.
JOURNAL OF SURGICAL RESEARCH (2013)
ERK-Dependent Downregulation of Skp2 Reduces Myc Activity with HGF, Leading to Inhibition of Cell Proliferation through a Decrease in Id1 Expression
Xiaoran Li et al.
MOLECULAR CANCER RESEARCH (2013)
Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling
Fabiola Cecchi et al.
CANCER CELL (2012)
Role of Nuclear Receptor Coactivator 3 (Ncoa3) in Pluripotency Maintenance
Zhaoting Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
Ying Wang et al.
MOLECULAR ENDOCRINOLOGY (2011)
HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors
Farbod Shojaei et al.
CANCER RESEARCH (2010)
The role of SRc-3 in human breast cancer
Ondrej Gojis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6
Keisuke Yanagida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer
Marisa G. Ponzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family
Jianming Xu et al.
NATURE REVIEWS CANCER (2009)
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma
Wen Xue et al.
GENES & DEVELOPMENT (2008)
G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth
Sandra M. Pasternack et al.
NATURE GENETICS (2008)
Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair
Yutaka Shimomura et al.
NATURE GENETICS (2008)
Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation
Asuka Kondo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes
Kwang-Hoon Song et al.
HEPATOLOGY (2007)
Acetylation of lysine 56 of histone H3 catalyzed by RTT109 and regulated by ASF1 is required for replisome integrity
Junhong Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells
Todd W. Bauer et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Hepatocyte growth factor induces redistribution of p21CIP1 and p27KIP1 through ERK-dependent p16INK4a up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells
JH Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration
H Ma et al.
CIRCULATION RESEARCH (2003)
Role of the steroid receptor coactivator SRC-3 in cell growth
G Zhou et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2
Y Tsukada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
